EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and full validation of a UPLC-MS/MS method for the simultaneous quantification of esketamine, noresketamine, and hydroxynoresketamine in beagle dog plasma and its application to a pharmacokinetic study

Wei Zhou, Zhe Guo, Yilong Li, Yanping Tu, Zhongfeng Zheng, Xiangjun Qiu

Frontiers in Pharmacology · 12.11.2026 · 17

DOI: 10.3389/fphar.2026.1961192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.11.2026. Verfasst von Wei Zhou und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esketamine (ESK), the S-enantiomer of ketamine, has garnered significant clinical interest as a rapid-acting antidepressant. Its pharmacokinetic profile is critically shaped by its major metabolites, noresketamine (NESK) and hydroxynoresketamine (HNESK), which may contribute to its overall pharmacological effects. Reliable bioanalytical methods for simultaneous quantification of ESK and these metabolites in preclinical species are essential for translational research.

Methods

We developed and comprehensively validated a highly sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the concurrent determination of ESK, NESK, and HNESK in beagle dog plasma. Analyte separation was achieved on a UPLC BEH C18 column (2.1 × 50 mm, 1.7 µm) using gradient elution with a mobile phase composed of acetonitrile and 0.1% formic acid in water at a flow rate of 0.4 mL/min, with a total run time of 4.0 min. Methoxyphenamine served as the internal standard. Detection was performed in positive electrospray ionization mode with multiple reaction monitoring, employing specific ion transition pairs for each target compound to guarantee selectivity and accuracy. Sample preparation involved a simple one-step protein precipitation with acetonitrile using only 100 µL of plasma.

Results

The method exhibited excellent linearity across the tested concentration ranges, with all calibration curves yielding determination coefficients (R 2 ) exceeding 0.999 7. The lower limits of quantification were 1 ng/mL for both ESK and NESK, and 0.5 ng/mL for HNESK. Intra- and inter-batch precision (RSD, %) ranged from 3.17% to 14.22% for ESK, 5.41%–10.94% for NESK, and 4.70%–12.40% for HNESK, while accuracy (RE, %) was within ±15% for all analytes. Matrix effects were well controlled (ME%: 93.27%–104.59%), and mean extraction recoveries exceeded 80.22%. Stability under relevant storage and handling conditions was also confirmed, along with satisfactory dilution integrity for 2-fold dilution. The validated method was successfully applied to a pharmacokinetic study in beagle dogs following a single intramuscular dose of 1.0 mg/kg ESK, providing reliable concentration-time profiles for all three analytes.

Conclusion

This is the first reported UPLC-MS/MS method enabling simultaneous quantification of ESK, NESK, and HNESK in beagle dog plasma. The assay features a short run time (4.0 min), simple sample preparation, low plasma volume requirement (100 µL), and excellent sensitivity, making it a robust and practical analytical tool for preclinical pharmacokinetic investigations and future mechanistic studies of ESK and its active metabolites.

Zitieren

APA

Zhou, W., Guo, Z., Li, Y., Tu, Y., Zheng, Z., & Qiu, X. (2026). Development and full validation of a UPLC-MS/MS method for the simultaneous quantification of esketamine, noresketamine, and hydroxynoresketamine in beagle dog plasma and its application to a pharmacokinetic study. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1961192

Vancouver

Zhou W, Guo Z, Li Y, Tu Y, Zheng Z, Qiu X. Development and full validation of a UPLC-MS/MS method for the simultaneous quantification of esketamine, noresketamine, and hydroxynoresketamine in beagle dog plasma and its application to a pharmacokinetic study. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1961192

BibTeX
@article{Zhou2026,
  author = {Zhou, Wei and Guo, Zhe and Li, Yilong and Tu, Yanping and Zheng, Zhongfeng and Qiu, Xiangjun},
  title = {Development and full validation of a UPLC-MS/MS method for the simultaneous quantification of esketamine, noresketamine, and hydroxynoresketamine in beagle dog plasma and its application to a pharmacokinetic study},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1961192}
}
Kostenlos starten →